<p>CARsgen Therapeutics Holdings Ltd. has filed a next day disclosure return with the Hong Kong Stock Exchange, announcing the repurchase of 320,000 ordinary shares at a total aggregate price of HKD 4,860,855. The repurchased shares will be held as treasury shares. Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. CARsgen Therapeutics Holdings Ltd. published the original content used to generate this news brief via IIS, the Issuer Information Service operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20251223-11965821), on December 23, 2025, and is solely responsible for the information contained therein. © Copyright 2025 - Public Technologies (PUBT)</p>

02171

<p>CARsgen Therapeutics Holdings Ltd. announced the repurchase of 320,000 ordinary shares for HKD 4.86 million, as per a filing with the Hong Kong Stock Exchange. The shares will be held as treasury shares. This information was disclosed via the Issuer Information Service of HKEX on December 23, 2025.</p>

CARsgen Therapeutics Repurchases 320,000 Shares for HKD 4.86 Million in HKEX Filing